ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.
PHILADELPHIA, Pennsylvania
Total Received
$376.3M
Total Awards
5
State
Pennsylvania
Last Updated
Feb 9, 2026
Yearly Funding Trend
$376.3M24
Top 5 Awards to ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through February 9, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_UG1CA189828_075 ECOG-ACRIN NCORP RESEARCH BASE - THE ECOG-ACRIN CANCER RESEARCH GROUP (EA) IS DEDICATED TO DECREASING THE BURDEN OF CANCER. EA IS A VIBRANT MEMBER OF THE NATIONAL CLINICAL TRIALS… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | PA-90 | 2024 | $183,616,051 |
ASST_NON_U10CA180820_075 ECOG-ACRIN NETWORK GROUP OPERATIONS CENTER - OVERALL: PUBLICLY-FUNDED CANCER CLINICAL TRIALS CONTINUE TO ESTABLISH NEW STANDARDS OF CARE AND IMPROVE OUTCOMES FOR CANCER PATIENTS.… | Department of Health and Human Services National Institutes of Health | 93.360 BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA), BIODEFENSE MEDICAL COUNTERMEASURE DEVELOPMENT | PA-90 | 2024 | $148,820,579 |
ASST_NON_U24CA196172_075 ECOG-ACRIN BIOSPECIMEN BANK TO SUPPORT NCTN - PROJECT SUMMARY ECOG-ACRIN (EA) REPRESENTS THE MERGER OF ECOG AND ACRIN TO FORM A COOPERATIVE GROUP FOCUSED ON PRACTICE-CHANGING CLIN… | Department of Health and Human Services National Institutes of Health | 93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH | PHILADELPHIA, PA-03 | 2024 | $36,939,788 |
ASST_NON_U01FD007943_075 REAL-WORLD DATA TO GENERATE REAL-WORLD EVIDENCE IN REGULATORY DECISION-MAKING - PROJECT SUMMARY THE RATIONALE FOR A MORE DETAILED UNDERSTANDING OF THE SAFETY AND EFFICACY OF NEW T… | Department of Health and Human Services Food and Drug Administration | 93.103 FOOD AND DRUG ADMINISTRATION RESEARCH | PHILADELPHIA, PA-03 | 2024 | $4,472,227 |
ASST_NON_U01CA274996_075 THE ECOG-ACRIN SUPPORT TRIAL: MULTILEVEL INTERVENTION TO IMPROVE DIVERSE ENROLLMENT IN CANCER CLINICAL TRIALS - ABSTRACT NATIONAL CANCER INSTITUTE (NCI) SUPPORTED CLINICAL TRIALS… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | PA-90 | 2024 | $2,477,466 |
Top 5 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Funding Agencies
View All→Federal Programs (CFDA)
View All→Source: USAspending.gov · All Recipients · Pennsylvania